Cristina De Juan, PhD
Founder & CEO at IMT Innovation
27 April to 27 April 2017
This is the future our speakers will envision on April 27th in London. Our event is an opportunity to discover the drivers of the Artificial intelligence and Machine Learning movement in healthcare. From robots helping children with autism to a breathalyser diagnosing disease, innovation is the highlight of our day.
We welcome these change-makers to share their future plans and spark meaningful conversation to go beyond the walls of our conference. How? We start by addressing where we are now and then asking what direction needs to be taken to create positive and meaningful integration of technology in healthcare for generations to come.
Welcome to The Future of Artificial Intelligence & Machine Learning in Healthcare!
Consultant General at The Royal London and St Bartholomew’s Hospitals
We will discover the tools that are redefining how we prevent, predict, diagnose and treat disease, the legal and regulatory implications of the technology and its impact on global business models. We will learn about:
Enjoy our wide-range of ticket options. For questions please reach out at email@example.com
Founder & CEO at IMT Innovation
Cristina is the founder and CEO of IMT, a marketplace for digital health, and the largest digital health network in UK. Prior to this, Cristina set up a government-based precision medicine innovation centre, and 2 medtech startups. Cristina used to run clinical trials for pharma, and holds a PhD in Genetics. Cristina is a council member of the Royal Society of Medicine and a faculty member of Barts X Medicine. She was recently been named one of the 100 most-influential leaders in healthtech in the world.View profile
Managing Director, Aviva Ventures
Ben Luckett is the Managing Director of Aviva Ventures. He set up the fund in August 2015 as part of Aviva’s Innovation Strategy. Prior to this Ben was the Strategy Director for the UKGI Business and has also held roles in Enterprise Risk and Finance. Ben represents Aviva on the East of England CBI regional council and is actively involved in supporting and mentoring local businesses. Prior to joining Aviva Ben was Senior Marketing Manager at Centrica. Ben started his career at Accenture where he was a change management consultant specialising in Customer Experience Design for Banking and Insurance clients.View profile
Developer Relations Programs Lead in the UK at Google
Rupert Whitehead is in the developer relations team at Google. He looks after developer communities, and Google's expert and agencies program for the UK and Ireland. This touches on technologies ranging from the web, mobile, cloud, VR/AR and machine learning. His main focus is to help developers become more successful with Google's APIs. Rupert is currently working with a number of machine learning groups to drive better collaboration. Before joining Google, Rupert worked in Nokia and Symbian.View profile
Professor of Affective & Behavioural Computing at Imperial College London
Professor Maja Pantic is one of the world's leading experts in the research on machine understanding of human behaviour including vision-based detection, tracking, and analysis of human behavioural cues like facial expressions and body gestures, and multimodal analysis of human behaviours like laughter, social signals, and affective states. In 2006, she joined Imperial College London where she is also the Chair of the Intelligent Behaviour Understanding Group (iBUG) working on machine analysis of human non-verbal behaviour.View profile
Consultant Ophthalmologist at Moorfields Eye Hospital, NIHR Clinician Scientist at Moorfields Eye Hospital
Pearse A. Keane, MD, FRCOphth, is a consultant ophthalmologist at Moorfields Eye Hospital, London and an NIHR Clinician Scientist, based at the Institute of Ophthalmology, University College London (UCL). Dr Keane specialises in applied ophthalmic research, with a particular interest in retinal imaging and new technologies. In April 2015, he was ranked no. 4 on a worldwide ranking of ophthalmologists under 40, published in "the Ophthalmologist” journal (https://theophthalmologist.com/the-power-list-2015/). In 2016, he initiated a formal collaboration between Moorfields Eye Hospital and Google DeepMind, with the aim of applying machine learning to automated diagnosis of optical coherence tomography (OCT) images.View profile
CEO and Co-founder at Owlstone Medical
Billy Boyle founded Owlstone Medical. The company produces the Owlstone detector, a ground-breaking solid state sensors device that uses micro- and nanofabrication techniques to detect a wide range of airborne or dissolved chemical agents. Owlstone Medical is running three large scale clinical trials to develop biomarkers for the early detection of cancer, and was recently named Invention of the Year in the 2017 Top 50 in Digital Health Awards. Prior to Owlstone, Billy was a Research Associate in the Microsystems and Nanotech group at the University of Cambridge.View profile
Global Co-Chair, Life Sciences Sector at DLA Piper
Bonella Ramsay is the Global Co-Chair of the Life Sciences Sector at DLA Piper. She is involved in IP rights management and strategy as well as structuring and negotiating the exploitation of IP rights. She has a particular focus on digital health and technology transactions for the pharmaceutical and biosciences sector.View profile
Partner at DLA Piper
Gareth Stokes is a partner at DLA Piper, focusing on information technology, outsourcing and intellectual property-driven contracts. Gareth's experience spans numerous complex major procurement and sourcing projects within heavily regulated industries. Gareth is currently focusing on AI across several sectors and the new legal challenges that tech poses.View profile
Investor at Kinnevik AB
Christian Scherrer is a venture and growth investor at Kinnevik, an entrepreneurial investment group focused on building digital consumer businesses including healthcare. Christian is focused on e-commerce platforms and marketplaces. His previous investment experience comes from working with J.P. Morgan and the Swiss National Bank.View profile
Investment Director & Head of Research at MMC Ventures
David Kelnar is Investment Director & Head of Research at MMC Ventures, a leading UK-based venture capital firm. David specialises in AI-led software companies. He published the first map of UK AI software companies, has met with more than 70 AI software providers, and is a frequent writer and speaker on AI. Previously, David served as CEO, and CFO, respectively of two consumer technology companies and is an advisor to a range of early stage ventures. Prior to this, David was an investor and analyst in the European technology sector, at Goldman Sachs in London and a hedge fund in New York.View profile
Clinical Lead at NHS England
Indra graduated from University College Medical School in London and works both as an Emergency Medicine specialist and a Health Policy Advisor for the Civil Service. She has a special interest in expedition and travel medicine and has completed many tours around the world working with voluntary organisations and the Olympic Committee. She spent 3 years researching the use of Web 2.0 technologies in healthcare and health informatics and published her findings internationally.View profile
Non-Executive Director at Atem NT
Jordi is Non-Exec. Director at Atem NT, a research company specialized in AI, HPC and Robotics. He is concurrently CTO at Spoonful of Sugar, a UCL spin-out company providing behaviour-change consultancy in Healthcare. He has more than 15 years’ experience as senior executive in consultancy and tech companies for Life Science industry. He is Ass. Professor of the Digital Economy Institute (ICEMD) of ESIC Business School. He holds a PhD in Telecom Eng. from Universitat Politècnica de Catalunya.View profile
General Manager for Software & CTO Europe at GE Healthcare
Nuno Godinho oversees all software development done in Europe in the healthcare space at GE, mainly focusing on the Cloud and Industrial Internet. Nuno has 16+ years experience working in industries like Banking, Healthcare, Retail, Telco, Insurance and Travel among others, from Developer to CTO and CIO. He is a recognized Thought Leader in the industry and invited to be a speaker in several industry major events like Cloud Banking Europe 2015, Software Architecture Conference and Microsoft TechEd Conferences, has been lately working in Cloud (Azure, AWS, Google and others), BigData and IoT.View profile
Manager of the Health and Person-Centered Systems at IBM Research
Spyros Kotoulas is a Research Scientist at IBM Research Ireland and the Manager of the Health and Person-Centered Systems research group. He is working on improving Healthcare and Social Care for vulnerable populations, aiming a better experience for the individual, increased effectiveness and reduced cost. His aspiration is to build personalised and person-centric systems that will positively disrupt the management and delivery of care. His research interests lie in artificial intelligence and data management for semi-structured data, parallel methods for data intensive processing, knowledge representation and reasoning, flexible data integration methods and the Internet of Things.View profile
Early Stage Investor at Balderton Capital
Early Stage Investor @Balderton enthusiastic about Big Data, ML & AI, BI, SaaS and DigitalHealth. Co-founder @DiversityVC. Prior to joining Balderton Capital, Anna worked with business angels investing and advising early-stage UK startups. Before moving to London, Anna spent three years in New York, where she worked as data product analyst at YipitData, building technical and operational skills while growing the data team. She started her career in telco M&A at Barclays, working on deals across Europe and the USA. Anna holds two masters degrees in International Business from HEC and the Indian Institute of Management in Bangalore, and a Bachelor in Management from HEC.View profile
Consultant General at The Royal London and St Bartholomew’s Hospitals
Dr Ahmed is a Consultant general, laparoscopic and colorectal surgeon working in the Academic Surgery Unit at The Royal London and St Bartholomew’s Hospitals. He is the Director for colorectal cancer within the trust. He has published widely on the genetics of colorectal cancers and completed a PhD at London University on this subject. He has been recently appointed as a council member to the highly prestigious Royal College of Surgeons of England and is its youngest member. He is the Associate Dean for undergraduates at Bart’s and the London medical school (the oldest medical school in England) and is head of Surgery in the clinical programme. He is the programme director for core surgical trainees and runs the simulation programme for the trainees and sits on the higher surgical committee. He is also the civilian advisor for surgery to the British armed forces. He has an academic interest in the use of wearables in education and clinical practice. Using Google glass he recently performed a live operation to 14000 students across 132 countries and 1100 cities to demonstrate this technology. He has developed Virtual Medics a web based platform using wearables for education. Bart’s and The London Medical School were the first medical school outside North America to incorporate the technology into the curriculum. He has now co-founded Medical Realities and is developing both AR and VR within the medical space.
Chief Commercial Officer at Babylon Health
Rabin is an accomplished Digital Media, Marketing and Marketplace executive and entrepreneur with extensive strategy, operating, sales and business development experience for global players such as Google and DoubleClick and multiple start-ups across North America, Europe and Israel. Prior to babylon, Rabin was President & COO of FindTheBest (now Graphiq) a data-driven comparison engine backed by Kleiner Perkins. Previously, Rabin was Director of Strategic Partnerships at Google, where he was responsible for launching and leading Google’s content, commerce and local partnerships across Europe, the Middle East and Africa. Prior to Google, he was global Vice President of Media at DoubleClick, responsible for globally expanding and ultimately selling the Company’s Media business. Rabin holds an MBA from Stanford University, and a BA and BS from the Wharton School of the University of Pennsylvania.View profile
33-35 Hoxton Square, London N1 6NN, UK
Located in Hoxton Square, the event will be hosted at Aviva's Digital Garage. Hoxton Square is at the heart of the East London Tech City, also called the Silicon Roundabout, which is located between Old Street and Shoreditch. London's Tech City is the third-largest tech startup hub in the world after San Francisco and New York City.
The closest tube station is Old Street which is approximately 6 min walk. Liverpool Street Station is approximately 10 min walk.
The closest overground train stations are Shoreditch High Street and Hoxton.
You can order an Uber, book a minicab or jump in a black cab.
Registration & Networking
|09:00||Welcome Remarks||Cristina De Juan, CEO & Founder InnovatemedtecBen Luckett, Managing Director, Aviva Ventures|
|09:10||Opening Keynote: How will Artificial Intelligence and Humans Work Together to Make Healthcare More Affordable and Accessible?||Rabin Yaghoubi, COO, Babylon Health|
|09:40||Panel: Trends & Challenges by Investors||Christian Scherrer. Investor, KinnevikDavid Kelnar, Investment Director, MMC VenturesAnna Boffetta, Early Stage Investor at Balderton|
|10:10||The Power of Artificial Intelligence, Face Recognition & Robots||Prof Maja Pantic, Prof of Affective & Behavioural Computing, Imperial College|
|11:00||Artificial Intelligence in Healthcare: When Machine Learning Meets Medical Doctors||Jordi Guitart, Non-Exec Director, Atem-NT|
|11:30||What Is Google Doing with Machine Learning?||Rupert Whitehead, Developer Relations, Google UK|
|11:55||How is Artificial Intelligence Changing the Delivery of Care?|
|12:25||Lunch & Networking|
|13:10||A Breathalyser for Disease: Saving 100,000 Lives||Billy Boyle, Founder & CEO, Owlstone Medical|
|13:40||Urgent Care Care in 2025 - Does Artificial Intelligence Have a Role?||Dr Indra Joshi, NHS England Clinical Lead|
|14:10||The Anatomy of an Artificial Intelligence / Digital Healthcare Collaboration||Bonella Ramsay, Global Life Sciences, DLA Piper LLPGareth Stokes, Partner, DLA Piper LLP|
|15:00||How Are Pharma Business Models Adapting to Machine Learning & Artificial Intelligence?||Nuno Godinho, GM Software GE Healthcare|
|15:30||Reinventing the Eye Examination - How New Techs Will Transform Healthcare||Dr Pearse Keane Consultant Ophthalmologist, Moorfields Eye Hospital|
|16:00||The Future of Healthcare||Shafi Ahmed, Cancer Surgeon at Royal London Hospital, Co-founder of Medical Realities|
|16:30||Close & Networking|
How will that healthcare look like? What will be different from today?
We will discuss the challenges and solve problems in artificial intelligence and machine learning in order to shape the healthcare of 2025. You will have a chance to share you ideas and challenges with the global drivers in the field, and walk away with a plan for better healthcare.
And we will discover the tools that are redefining how we prevent, predict, diagnose and treat disease, the legal and regulatory implications of the technology, and its impact on global business models.
Our speakers and their knowledge are key in our agenda. We have provided this unique opportunity to learn from and interact with world-leaders in the Artificial Intelligence and Machine Learning space. The are the innovators, drivers of this future, and they are ours for a day.
Do not miss out.
Enjoy our wide-range of ticket options. For questions please reach out at firstname.lastname@example.org.
We want you to connect with key stakeholders, our community of influencers, innovators and investors and increase your brand visibility within the emerging Artificial Intelligence and Machine Learning market. We want you because of your continued contribution to innovation and technology. Start your journey with the most curious minds in the ecosystem on the 27th of April.
This event will allow you to interface with the key stakeholders, providing a powerful opportunity to build important relationships and increase brand visibility.
Such an environment offers participating companies the ability to establish themselves as leaders in the industry, expand the presence of their products and services in the global marketplace, and enhance return on investment.
Enjoy our wide-range of ticket options. For questions, please reach out at email@example.com.
We have several tickets available to suit your individual needs:
For enquiries or questions, please reach out at firstname.lastname@example.org
Aviva Ventures has kindly provided the venue facilities and refreshments at the Aviva Digital Garage. Aviva Ventures is Aviva’s corporate venture capital fund, investing in innovative and disruptive businesses that will shape the future of insurance.
The Bayer Grants4Apps program offers 2 initiatives this year: for early stage digital health startups, the Accelerator offers mentoring by entrepreneurs and Bayer experts, space for 100 days, and funding of 50,000€ per startup. Up to 5 startups will be selected for this year's program, based on business, team expertise and level of innovation.
For mature startups and companies, Grants4Apps offers the Dealmaker program. In focus are companies working on solutions to particular challenges which are published on the website. Some of the challenges deal with artificial intelligence technologies, detection of endometriosis, or clinical trials. The companies selected will be invited to Berlin (travel costs are funded) for a one day event with business, legal and IT to discuss possible project and collaboration options.
To find out more, please visit their website: grants4apps.com/berlin
The IET is one of the largest multidisciplinary membership organisations with over 167,000 members operating in over 127 countries in the world that encompasses all the disciplines in engineering and technology. For this reason, the healthcare sector is one of the areas that they have endeavoured to diversify, to be able to make a significant impact in the development of the world. Their passion is engineering a better world through collaborative means supporting technology innovation to meet the needs of society.
Backing Europe's breakthrough technology businesses. Our partnership consists of some of Europe's most successful entrepreneurs and venture investors. By bringing their combined experience to bear, we enable our portfolio companies to access an unrivalled array of knowledge, skills and capital. Our focus is on ambitious entrepreneurs, disruptive technology and sustainable businesses.
MSD is a global healthcare company and Wayra UK, Telefonica Open Future’s digital start up accelerator, launched Velocity Health in 2015 to challenge the digital start-up community to create solutions that reimagine how healthcare can be delivered in the UK to help improve patient outcomes. After a hugely successful first year focusing on prevention, MSD and Wayra UK will continue their commitment to Velocity Health and will focus again on the Five Year Forward View for 2017.
Professor Maja Pantic, Imperial College London
Cristina De Juan, CEO of IMT, and Spyros Kotoulas, Manager of the Health and Person-Centered Systems at IBM Research
The investor panel - David Kelnar, MMC Ventures; Christian Scherrer, Kinnevik; Anna Boffetta, Balderton Capital
Jordi from Atem NT and Hector
Rupert Whitehead, Developer Relations at Google
Spyros from IBM and Simon
Dr Shafi Ahmed, Consultant General at The Royal London & St Bartholomew’s Hospitals, Co-founder of Medical Realities
Cristina from IMT, Jordi from Atem NT and Andoni
The IMT Team
The venue will be kindly provided by